Home › Targets › CD8

CD8 (1 companies · 2 programs)

Companies with an active program directed at CD8.

Sana Biotechnology, Inc. SANA

SG227 — Multiple Myeloma Preclinical
SG293 — Non-Hodgkin Lymphoma Preclinical